RSI společnosti IMV
Jaká je hodnota metriky RSI společnosti IMV?
Hodnota metriky RSI společnosti IMV, Inc. je 60.99
Jaká je definice metriky RSI?
Index relativní síly (Relative strength index - RSI 14) je technický ukazatel, který se řadí mezi momentum indikátory a měří rychlost a změnu ceny. Jeho hodnota se pohybuje mezi 0 a 100 a používá se k charakterizování překupovaného a přeprodaného stavu.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI společností v sektoru Health Care sektor na TSX ve srovnání se společností IMV
Čemu se věnuje společnost IMV?
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
Firmy s metrikou rsi podobnou společnosti IMV
- Hodnota metriky RSI společnosti Magellan Health Inc je 60.98
- Hodnota metriky RSI společnosti DSV A/S je 60.98
- Hodnota metriky RSI společnosti Doman Building Materials je 60.98
- Hodnota metriky RSI společnosti Nokia Oyj je 60.98
- Hodnota metriky RSI společnosti Monster Beverage je 60.98
- Hodnota metriky RSI společnosti The Toronto-Dominion Bank je 60.98
- Hodnota metriky RSI společnosti IMV je 60.99
- Hodnota metriky RSI společnosti Lyxor Index Fund - Lyxor EuroMTS 1-3Y Italy BTP Government Bond (DR) UCITS ETF je 61.00
- Hodnota metriky RSI společnosti Trajan Ltd je 61.00
- Hodnota metriky RSI společnosti Ellington je 61.00
- Hodnota metriky RSI společnosti Ultracab (India) je 61.00
- Hodnota metriky RSI společnosti Ralph Lauren A Dl ,01 je 61.00
- Hodnota metriky RSI společnosti Lloyd Fonds AG je 61.00